𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

✍ Scribed by Hainsworth, J. D.

Book ID
127167958
Publisher
American Society of Clinical Oncology
Year
2003
Tongue
English
Weight
73 KB
Volume
21
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with fludarabine and
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network
✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO

Weekly combination chemotherapy with doc
Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial
✍ John D. Hainsworth; Donna Carrell; Ronald L. Drengler; Carroll Scroggin Jr.; F. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract ## BACKGROUND The goal of the current study was to evaluate the feasibility, toxicity, and efficacy of a novel combination of weekly docetaxel and gemcitabine for elderly patients and patients with poor performance status who had advanced‐stage small cell lung carcinoma (SCLC). ## MET